YEWB Stock Analysis
YE
Uncovered
Yew Bio-Pharm Group Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Yew Bio-Pharm Group, Inc. is a holding company, which engages in growing and selling yew trees, and manufacturing of products made from yew trees in China. The company is headquartered in El Monte, California. The company went IPO on 2007-12-18. The firm is engaged in manufacturing and sale of products made from yew trees and branches and leaves of yew trees for the manufacture of traditional Chinese medicine (TCM) containing taxol. The Company’s segments include PRC and USA. PRC segment manages and reviews the business of Harbin Yew Science and Technology Development Co., Ltd. (HDS), Heilongjiang Jinshangjing Bio-Technology Development Co., Limited (JSJ), Harbin Yew Food Co., Ltd (HYF) and Yew (Guangzhou) Bio-Technology Co., Ltd (YBT). USA segment manages and reviews the business of Yew Bio-Pharm (HK), and MC Commerce Holding Inc. (MC). The Company’s products include yew seedling products and yew handicraft products such as yew candles, yew essential oil soap, pine needle extract, complex taxus cuspidate extract, and composite northeast yew extract.